Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complete remission in a patient with JAK2- and IDH2-positive myelofibrosis.

Blood - 11 Aug 2016

Masarova Lucia, Wang Wei, Newberry Kate J, Kantarjian Hagop, Verstovsek Srdan

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Isocitrate Dehydrogenase
Share to Janus Kinase 2
Share to Nitriles
Share to Primary Myelofibrosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pyrazoles

Share to Pyrimidines

Share to Remission Induction

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 27325105
DOI: 10.1182/blood-2016-03-705012
PMCID: PMC4982456

Genes

IDH2
JAK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Complete remission in a patient with JAK2- and IDH2-positive myelofibrosis.PMID 27325105Read ↗

JAK2 inhibitors in myelofibrosis.Semantic proximity Read ↗

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic featuresSemantic proximity Read ↗

JAK2 inhibitors and myeloproliferative neoplasms.Semantic proximity Read ↗

Two CML patients who subsequently developed features of essential thrombocythemia with JAK2-V617F mutation while in complete cytogenetic remission after treatment with imatinib mesylate.Semantic proximity Read ↗

A case of JAK2 V617F positive essential thrombocythemia successfully controlled by imatinib mesylate.Semantic proximity Read ↗

Idiopathic myelofibrosis and pyoderma gangrenosum involving a mutation of Janus kinase 2 (JAK2V617F), showing poor prognosis.Semantic proximity Read ↗

Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia.Semantic proximity Read ↗

Successful Hematopoietic Stem Cell Transplantation in a Patient with Complete IFN-γ Receptor 2 Deficiency: a Case Report and Literature Review.Semantic proximity Read ↗

Resolution of post-polycythaemic myelofibrosis with a combination of thalidomide and interferon.Semantic proximity Read ↗

Relapse of postpolycythemia myelofibrosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation.Semantic proximity Read ↗

Medical progress in idiopathic myelofibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.